Symbols / APYX Stock $3.72 -2.11% Apyx Medical Corporation

Healthcare • Medical Devices • United States • NMS
APYX (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Mr. Charles D. Goodwin II
Exch · Country NMS · United States
Market Cap 155.60M
Enterprise Value 163.50M
Income -11.21M
Sales 52.84M
FCF (ttm) -7.11M
Book/sh 0.35
Cash/sh 0.76
Employees 205
Insider 10d —
IPO Jan 02, 2019
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -13.19
PEG 0.59
P/S 2.94
P/B 10.69
P/C —
EV/EBITDA -28.23
EV/Sales 3.09
Quick Ratio 4.16
Current Ratio 5.00
Debt/Eq 265.25
LT Debt/Eq —
EPS (ttm) -0.27
EPS next Y -0.28
EPS Growth —
Revenue Growth 34.70%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-07
Earnings (prior) 2026-03-10
ROA -6.12%
ROE -76.15%
ROIC —
Gross Margin 62.53%
Oper. Margin 0.06%
Profit Margin -21.22%
Shs Outstand 41.83M
Shs Float 29.09M
Insider Own 13.27%
Instit Own 46.11%
Short Float 0.50%
Short Ratio 1.52
Short Interest 195.81K
52W High 4.50
vs 52W High -17.33%
52W Low 0.85
vs 52W Low 338.16%
Beta 1.54
Impl. Vol. 1.78%
Rel Volume 0.45
Avg Volume 126.89K
Volume 57.72K
Target (mean) $6.40
Tgt Median $6.00
Tgt Low $6.00
Tgt High $8.00
# Analysts 5
Recom Strong_buy
Prev Close $3.80
Price $3.72
Change -2.11%
About

Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company's helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$6.40
Mean price target
2. Current target
$3.72
Latest analyst target
3. DCF / Fair value
$-3.06
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$3.72
Low
$6.00
High
$8.00
Mean
$6.40

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-11 main Craig-Hallum Buy → Buy $6
2026-03-11 up BTIG Neutral → Buy $6
2025-12-16 init Roth Capital — → Buy $6
2025-11-12 up Citizens Market Perform → Market Outperform $8
2024-10-17 init BTIG — → Neutral —
2024-09-16 reit JMP Securities — → Market Perform —
2023-11-10 main Stephens & Co. Overweight → Overweight $5
2023-08-11 main Piper Sandler Overweight → Overweight $5
2023-07-14 init Stephens & Co. — → Overweight $8
2023-06-15 main Lake Street — → Buy $9
2023-05-24 reit JMP Securities — → Market Perform —
2023-05-12 main Lake Street Buy → Buy $6
2022-08-12 main Piper Sandler — → Overweight $12
2022-07-19 main Lake Street — → Buy $17
2022-05-20 init Lake Street — → Buy $12
2021-08-13 main JMP Securities — → Market Outperform $14
2020-05-12 main JMP Securities — → Market Outperform $5
2019-11-12 main Piper Sandler — → Overweight $10
2019-04-02 main JMP Securities Market Outperform → Market Outperform $8
News
RSS: Latest APYX news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-13 CITRONOWICZ MOSHE Officer — 37,000 $1.80 $66,600
2026-01-27 ROMAN SHAWN DAVID Chief Operating Officer — 12,000 $1.80 $21,600
2024-08-13 HILL MATTHEW C Chief Financial Officer — 5,336 $1.13 $6,030
2024-08-13 HILL MATTHEW C Chief Financial Officer — 6,000 $1.13 $6,780
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
52.84
+9.86%
48.10
-8.11%
52.35
+17.61%
44.51
Operating Revenue
52.84
+9.86%
48.10
-8.11%
52.35
+17.61%
44.51
Cost Of Revenue
19.80
+5.65%
18.74
+0.82%
18.59
+20.88%
15.38
Reconciled Cost Of Revenue
19.80
+5.65%
18.74
+0.82%
18.59
+20.88%
15.38
Gross Profit
33.04
+12.55%
29.36
-13.03%
33.76
+15.89%
29.13
Operating Expense
39.49
-18.08%
48.20
-10.25%
53.71
+1.93%
52.69
Research And Development
3.37
-33.60%
5.08
-6.62%
5.44
+19.72%
4.54
Selling General And Administration
36.12
-16.25%
43.12
-10.66%
48.27
+0.25%
48.15
General And Administrative Expense
36.12
-16.25%
43.12
-10.66%
48.27
+0.25%
48.15
Salaries And Wages
14.01
-19.26%
17.35
-8.87%
19.04
+2.26%
18.62
Other Gand A
22.11
-14.22%
25.77
-11.83%
29.23
-1.01%
29.53
Total Expenses
59.29
-11.44%
66.95
-7.40%
72.30
+6.21%
68.07
Operating Income
-6.45
+65.79%
-18.84
+5.54%
-19.95
+15.33%
-23.56
Total Operating Income As Reported
-6.45
+65.79%
-18.84
-9.19%
-17.26
+26.75%
-23.56
EBITDA
-4.59
+72.67%
-16.80
+7.24%
-18.11
+17.70%
-22.01
Normalized EBITDA
-4.59
+72.67%
-16.80
+5.16%
-17.72
+19.49%
-22.01
Reconciled Depreciation
0.66
+9.35%
0.60
-13.44%
0.69
-22.25%
0.89
EBIT
-5.25
+69.85%
-17.40
+7.47%
-18.80
+17.87%
-22.90
Total Unusual Items
—
0.00
+100.00%
-0.40
0.00
Total Unusual Items Excluding Goodwill
—
0.00
+100.00%
-0.40
0.00
Special Income Charges
—
0.00
+100.00%
-0.40
0.00
Other Special Charges
—
—
0.40
—
Net Income
-11.21
+52.22%
-23.46
-25.38%
-18.71
+19.28%
-23.18
Pretax Income
-10.84
+53.51%
-23.31
-9.52%
-21.28
+7.11%
-22.91
Net Non Operating Interest Income Expense
-4.48
-4.19%
-4.30
-176.24%
-1.56
-1196.48%
0.14
Interest Expense Non Operating
5.59
-5.38%
5.91
+138.38%
2.48
+16420.00%
0.01
Net Interest Income
-4.48
-4.19%
-4.30
-176.24%
-1.56
-1196.48%
0.14
Interest Expense
5.59
-5.38%
5.91
+138.38%
2.48
+16420.00%
0.01
Interest Income Non Operating
1.11
-31.01%
1.61
+74.38%
0.92
+486.62%
0.16
Interest Income
1.11
-31.01%
1.61
+74.38%
0.92
+486.62%
0.16
Other Income Expense
0.09
+157.14%
-0.16
-171.24%
0.23
-55.60%
0.51
Other Non Operating Income Expenses
0.09
+157.14%
-0.16
-125.88%
0.62
+22.20%
0.51
Tax Provision
0.27
+7.14%
0.25
+110.36%
-2.43
-762.67%
0.37
Tax Rate For Calcs
0.00
+0.00%
0.00
+84.21%
0.00
-45.71%
0.00
Tax Effect Of Unusual Items
0.00
0.00
+100.00%
-0.05
0.00
Net Income Including Noncontrolling Interests
-11.11
+52.86%
-23.56
-24.98%
-18.85
+19.02%
-23.28
Net Income From Continuing Operation Net Minority Interest
-11.21
+52.22%
-23.46
-25.38%
-18.71
+19.28%
-23.18
Net Income From Continuing And Discontinued Operation
-11.21
+52.22%
-23.46
-25.38%
-18.71
+19.28%
-23.18
Net Income Continuous Operations
-11.11
+52.86%
-23.56
-24.98%
-18.85
+19.02%
-23.28
Minority Interests
-0.11
-210.42%
0.10
-29.93%
0.14
+45.74%
0.09
Normalized Income
-11.21
+52.22%
-23.46
-27.78%
-18.36
+20.80%
-23.18
Net Income Common Stockholders
-11.21
+52.22%
-23.46
-25.38%
-18.71
+19.28%
-23.18
Diluted EPS
-0.27
+59.09%
-0.66
-22.22%
-0.54
+19.40%
-0.67
Basic EPS
-0.27
+59.09%
-0.66
-22.22%
-0.54
+19.40%
-0.67
Basic Average Shares
41.09
+15.62%
35.54
+2.66%
34.62
+0.31%
34.52
Diluted Average Shares
41.09
+15.62%
35.54
+2.66%
34.62
+0.31%
34.52
Diluted NI Availto Com Stockholders
-11.21
+52.22%
-23.46
-25.38%
-18.71
+19.28%
-23.18
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
66.84
+3.08%
64.84
-18.17%
79.24
+53.05%
51.77
Current Assets
58.47
+3.60%
56.44
-19.79%
70.36
+63.74%
42.97
Cash Cash Equivalents And Short Term Investments
31.74
0.00%
31.74
-27.29%
43.65
+328.30%
10.19
Cash And Cash Equivalents
31.74
0.00%
31.74
-27.29%
43.65
+328.30%
10.19
Receivables
16.78
+8.37%
15.48
+10.39%
14.02
-23.14%
18.25
Accounts Receivable
16.78
+8.37%
15.48
+10.39%
14.02
+32.27%
10.60
Allowance For Doubtful Accounts Receivable
-1.02
-2.00%
-1.00
-64.47%
-0.61
+8.98%
-0.67
Other Receivables
—
—
0.03
-69.70%
0.10
Taxes Receivable
—
—
0.00
-100.00%
7.54
Inventory
8.60
+13.72%
7.56
-23.77%
9.92
-15.89%
11.80
Raw Materials
4.88
+22.95%
3.97
-3.38%
4.11
-17.41%
4.98
Work In Process
2.19
+14.44%
1.92
-15.02%
2.26
+4.49%
2.16
Finished Goods
2.73
+0.89%
2.71
-38.93%
4.43
-13.41%
5.12
Prepaid Assets
—
—
—
—
Other Current Assets
1.35
-18.25%
1.66
-40.12%
2.76
+0.99%
2.74
Total Non Current Assets
8.37
-0.39%
8.40
-5.36%
8.88
+0.85%
8.80
Net PPE
6.62
-1.80%
6.74
-5.71%
7.15
-5.80%
7.59
Gross PPE
10.91
+1.71%
10.73
+0.55%
10.67
-15.51%
12.63
Accumulated Depreciation
-4.29
-7.62%
-3.99
-13.26%
-3.52
+30.13%
-5.04
Properties
0.00
0.00
0.00
0.00
Land And Improvements
—
—
0.00
-100.00%
1.60
Buildings And Improvements
—
—
0.00
-100.00%
4.43
Machinery Furniture Equipment
4.99
+21.82%
4.10
+5.02%
3.90
-8.06%
4.24
Construction In Progress
0.16
-74.49%
0.64
+58.75%
0.40
-21.10%
0.51
Other Properties
5.39
-5.57%
5.71
-7.17%
6.15
+268.06%
1.67
Leases
0.36
+28.47%
0.28
+32.55%
0.21
+19.10%
0.18
Other Non Current Assets
1.75
+5.29%
1.66
-3.93%
1.73
+42.32%
1.22
Total Liabilities Net Minority Interest
52.01
+2.97%
50.51
-3.46%
52.32
+274.18%
13.98
Current Liabilities
11.70
+9.13%
10.72
-15.85%
12.74
+7.51%
11.85
Payables And Accrued Expenses
8.88
-8.20%
9.67
-6.45%
10.34
-3.76%
10.74
Payables
3.06
+16.94%
2.62
-3.58%
2.71
-42.88%
4.75
Accounts Payable
3.06
+16.94%
2.62
-3.58%
2.71
+1.61%
2.67
Current Accrued Expenses
5.82
-17.51%
7.06
-7.47%
7.63
+27.22%
6.00
Pensionand Other Post Retirement Benefit Plans Current
1.75
0.00
-100.00%
1.54
0.00
Total Tax Payable
—
—
0.00
-100.00%
2.08
Current Debt And Capital Lease Obligation
0.43
+20.56%
0.35
-3.27%
0.37
+45.06%
0.25
Current Capital Lease Obligation
0.43
+20.56%
0.35
-3.27%
0.37
+45.06%
0.25
Current Deferred Liabilities
0.64
-7.22%
0.69
+42.01%
0.49
-42.79%
0.85
Current Deferred Revenue
0.64
-7.22%
0.69
+42.01%
0.49
-42.79%
0.85
Other Current Liabilities
—
—
—
2.08
Total Non Current Liabilities Net Minority Interest
40.31
+1.31%
39.79
+0.53%
39.58
+1756.38%
2.13
Long Term Debt And Capital Lease Obligation
38.91
+1.31%
38.41
+0.72%
38.13
+6922.84%
0.54
Long Term Debt
34.85
+2.82%
33.89
+2.13%
33.19
—
Long Term Capital Lease Obligation
4.06
-10.03%
4.52
-8.75%
4.95
+811.42%
0.54
Non Current Deferred Liabilities
1.05
-6.08%
1.12
-10.27%
1.25
-11.51%
1.41
Non Current Deferred Revenue
1.05
-6.08%
1.12
-10.27%
1.25
-11.51%
1.41
Other Non Current Liabilities
0.35
+33.98%
0.26
+30.81%
0.20
+9.39%
0.18
Stockholders Equity
14.54
+2.32%
14.21
-46.78%
26.70
-28.95%
37.58
Capital Stock
0.04
+10.53%
0.04
+8.57%
0.04
+0.00%
0.04
Common Stock
0.04
+10.53%
0.04
+8.57%
0.04
+0.00%
0.04
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
41.79
+10.56%
37.79
+9.09%
34.64
+0.13%
34.60
Ordinary Shares Number
41.79
+10.56%
37.79
+9.09%
34.64
+0.13%
34.60
Additional Paid In Capital
103.62
+12.53%
92.08
+13.52%
81.11
+10.69%
73.28
Retained Earnings
-89.12
-14.39%
-77.91
-43.09%
-54.45
-52.37%
-35.73
Minority Interest
0.29
+132.80%
0.12
-43.44%
0.22
+4.74%
0.21
Total Equity Gross Minority Interest
14.83
+3.46%
14.34
-46.75%
26.92
-28.76%
37.79
Total Capitalization
49.39
+2.67%
48.10
-19.68%
59.89
+59.35%
37.58
Working Capital
46.77
+2.30%
45.72
-20.66%
57.62
+85.15%
31.12
Invested Capital
49.39
+2.67%
48.10
-19.68%
59.89
+59.35%
37.58
Total Debt
39.34
+1.49%
38.76
+0.68%
38.50
+4736.81%
0.80
Net Debt
3.11
+44.47%
2.15
—
—
Capital Lease Obligations
4.49
-7.80%
4.87
-8.37%
5.32
+567.84%
0.80
Net Tangible Assets
14.54
+2.32%
14.21
-46.78%
26.70
-28.95%
37.58
Tangible Book Value
14.54
+2.32%
14.21
-46.78%
26.70
-28.95%
37.58
Inventories Adjustments Allowances
-1.21
-16.96%
-1.03
-17.94%
-0.88
-91.47%
-0.46
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-8.00
+55.67%
-18.05
-243.82%
-5.25
+74.12%
-20.28
Cash Flow From Continuing Operating Activities
-8.00
+55.67%
-18.05
-243.82%
-5.25
+74.12%
-20.28
Net Income From Continuing Operations
-11.11
+52.86%
-23.56
-24.98%
-18.85
+19.02%
-23.28
Depreciation Amortization Depletion
0.66
+9.35%
0.60
-13.44%
0.69
-22.25%
0.89
Depreciation And Amortization
0.66
+9.35%
0.60
-13.44%
0.69
-22.25%
0.89
Other Non Cash Items
1.04
-17.89%
1.27
+100.79%
0.63
—
Stock Based Compensation
2.00
-50.14%
4.01
-21.53%
5.11
-23.64%
6.70
Provisionand Write Offof Assets
0.98
+13.33%
0.86
-18.81%
1.06
+92.22%
0.55
Operating Gains Losses
0.02
+46.15%
0.01
-97.67%
0.56
+642.67%
0.07
Gain Loss On Sale Of PPE
0.02
+46.15%
0.01
+100.51%
-2.53
-3474.67%
0.07
Change In Working Capital
-1.59
-27.79%
-1.25
-122.46%
5.54
+206.25%
-5.22
Change In Receivables
-1.32
+35.23%
-2.04
-151.25%
3.97
+97.07%
2.02
Changes In Account Receivables
-1.32
+35.23%
-2.04
+43.06%
-3.57
-286.34%
1.92
Change In Inventory
-1.07
-147.46%
2.26
+55.11%
1.46
+126.20%
-5.57
Change In Prepaid Assets
0.24
-72.35%
0.86
+555.85%
-0.19
+64.05%
-0.52
Change In Payables And Accrued Expense
0.56
+124.21%
-2.33
-874.09%
0.30
+126.38%
-1.14
Change In Accrued Expense
0.21
+109.22%
-2.27
-921.38%
0.28
+122.85%
-1.21
Change In Payable
0.35
+663.49%
-0.06
-352.00%
0.03
-62.69%
0.07
Change In Account Payable
0.35
+663.49%
-0.06
-352.00%
0.03
-62.69%
0.07
Investing Cash Flow
-1.11
-54.29%
-0.72
-110.72%
6.73
+766.73%
-1.01
Cash Flow From Continuing Investing Activities
-1.11
-54.29%
-0.72
-110.72%
6.73
+766.73%
-1.01
Net PPE Purchase And Sale
-1.11
-54.29%
-0.72
-110.72%
6.73
+766.73%
-1.01
Purchase Of PPE
-1.11
-54.29%
-0.72
-35.46%
-0.53
+47.23%
-1.01
Sale Of PPE
—
0.00
-100.00%
7.27
0.00
Capital Expenditure
-1.11
-54.29%
-0.72
-35.46%
-0.53
+47.23%
-1.01
Financing Cash Flow
9.58
+42.03%
6.75
-79.03%
32.17
+14723.04%
0.22
Cash Flow From Continuing Financing Activities
9.58
+42.03%
6.75
-79.03%
32.17
+14723.04%
0.22
Net Issuance Payments Of Debt
-0.02
+0.00%
-0.02
-100.06%
35.04
+23775.00%
-0.15
Issuance Of Debt
—
0.00
-100.00%
46.11
0.00
Repayment Of Debt
-0.02
+0.00%
-0.02
+99.82%
-11.07
-7377.70%
-0.15
Long Term Debt Issuance
—
0.00
-100.00%
46.11
0.00
Long Term Debt Payments
-0.02
+0.00%
-0.02
+99.82%
-11.07
-7377.70%
-0.15
Net Long Term Debt Issuance
-0.02
+0.00%
-0.02
-100.06%
35.04
+23775.00%
-0.15
Net Common Stock Issuance
9.30
+32.86%
7.00
0.00
—
Proceeds From Stock Option Exercised
0.49
0.00
-100.00%
0.09
-76.44%
0.36
Net Other Financing Charges
-0.19
+20.00%
-0.23
+92.06%
-2.96
—
Effect Of Exchange Rate Changes
-0.47
-512.39%
0.11
+159.16%
-0.19
-148.35%
0.40
Beginning Cash Position
31.74
-27.29%
43.65
+328.30%
10.19
-66.98%
30.87
End Cash Position
31.74
0.00%
31.74
-27.29%
43.65
+328.30%
10.19
Free Cash Flow
-9.12
+51.44%
-18.77
-224.61%
-5.78
+72.84%
-21.29
Interest Paid Supplemental Data
4.64
-2.32%
4.75
+145.27%
1.94
+12800.00%
0.01
Income Tax Paid Supplemental Data
0.26
-32.46%
0.38
+16.11%
0.33
+157.03%
0.13
Common Stock Issuance
9.30
+32.86%
7.00
0.00
—
Issuance Of Capital Stock
9.30
+32.86%
7.00
0.00
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category